[ad_1] WOODCLIFF LAKE, N.J., September 28, 2018 / PRNewswire / – Eisai Inc. announced today that the United States Food and Drug Administration (FDA) has expanded the indication of its antiepileptic drug …
Read More »Eisai Announces FDA Approval of FYCOMPA® in Pediatric Patients From the Age of 4 Years for the Treatment of Partial Seizures
